Daniel G. Glaze, M.D.
Medical Director: Blue Bird Circle Rett Center and
Texas Children's Sleep Center
Daniel G. Glaze, M.D.
6701 Fannin, CC1250
Houston, TX 77030-2399
Baylor College of Medicine - M.D.
Baylor College of Medicine - Child Neurology Residency
- American Board of Pediatrics
- American Board of Neurology
- American Board of Neurology, Special Competency in Neurophysiology
- American Board of Sleep Medicine
Current Positions in Professional Organizations
- Member - Child Neurology Society
- Member - American Society of EEG Technology
- Member - American Clinical Neurophysiology Society
- Member - American Neurological Association
- Member - American Sleep Disorders Association
- Member - American Academy of Sleep Medicine, Task Force
- Primary interests in epilepsy, sleep disorders, and Rett Syndrome
- Neurophysiological manifestations of Rett Syndrome with focus upon sleep and seizure problems
- Rare Disease Clinical Research Consortium for New Therapeutics and New Diagnostics. D. Glaze, PI - Rett Syndrome Project. The goals of this project are to establish Rare Disease Clinical Research Centers and to study three rare diseases: Rett, Angelman and Prader-Willi syndromes.
- Autism Treatment Network: A Cooperative Multi-Center Program for Comprehensive Care and Treatment of Autism. D.Treadwell-Deering, PI; D. Glaze, Co-Investigator. The goals of the Autism Treatment Network are as follows: (1) to improve medical treatment of children and adolescents with autism by establishing standards of clinical care based on shared clinical practice and evidence from clinical outcomes; (2) to etablishing these standards of care for autism in the medical community through open research collaboration, trainee mentorship, and conferences; (3) to contribute to a national database of clinical information that will inform best practices and contribute to efforts to improve insurance reimbursements for autism care.
- Autism Intervention Research Network for Physical Health. D. Treadwell-Deering, PI; D. Glaze, Co-Investigator. The major goal of this study is to expand a clinical research network devoted to studying and improving care for physical health conditions among children with autism.
- Glaze DG, Percy AK, Skinner S, Motil KJ, Neul JL, Barrish JO, Lane JB, Geerts SP, Annese F, Graham J, McNair L, Lee HS. Epilepsy and the natural history of Rett syndrome. Neurology. 2010; 74(11):909-12.
- Kirby RS, Lane JB, Childers J, Skinner SA, Annese F, Barrish JO, Glaze DG, Macleod P, Percy AK. Longevity in Rett syndrome: analysis of the North American Database. J Pediatr. 2010; 156(1):135-138.e1.
- Ramocki MB, Peters SU, Tavyev YJ, Zhang F, Carvalho CM, Schaaf CP, Richman R, Fang P, Glaze DG, Lupski JR, Zoghbi HY. Autism and other neuropsychiatric symptoms are prevalent in individuals with MeCP2 duplication syndrome. Ann Neurol. 2009; 66(6):771-82. (PubMed)
- Percy AK, Lee HS, Neul JL, Lane JB, Skinner SA, Geerts SP, Annese F, Graham J, McNair L, Motil KJ, Barrish JO, Glaze DG. Profiling scoliosis in Rett syndrome. Pediatr Res. 2009. (PubMed)
- Samaco RC, Mandel-Brehm C, Chao HT, Ward CS, Fyffe-Maricich SL, Ren J, Hyland K, Thaller C, Maricich SM, Humphreys P, Greer JJ, Percy A, Glaze DG, Zoghbi HY, Neul JL. Loss of MeCP2 in aminergic neurons causes cell-autonomous defects in neurotransmitter synthesis and specific behavioral abnormalities. Proc Natl Acad Sci U S A. 2009;106(51):21966-71. (PubMed)
- Motil KJ, Morrissey M, Caeg E, Barrish JO, Glaze DG. Gastrostomy placement improves height and weight gain in girls with Rett syndrome. J Pediatr Gastroenterol Nutr. 2009; 49(2):237-42. (PubMed)
- Glaze DG, Percy AK, Motil KJ, Lane JB, Isaacs JS, Schultz RJ, Barrish JO, Neul JL, O'Brien WE, Smith EO. A study of the treatment of Rett syndrome with folate and betaine. J Child Neurol. 2009; 24(5):551-6. (PubMed)
- Motil KJ, Ellis KJ, Barrish JO, Caeg E, Glaze DG. Bone mineral content and bone mineral density are lower in older than in younger females with Rett syndrome. Pediatr Res. 2008; 64(4):435-9. (PubMed)
- Neul JL, Fang P, Barrish J, Lane J, Caeg EB, Smith EO, Zoghbi H, Percy A, Glaze DG. Specific mutations in methyl-CpG-binding protein 2 confer different severity in Rett syndrome. Neurology. 2008; 70(16):1313-21. (PubMed)